最新观点
Insights From Our Experts
Articles
Emerging Trends in the APAC MedTech Market
Content for this article was contributed by EVERSANA’s Asia Pacific team. APAC’s MedTech market will soon be the second largest in the world. This growth presents both opportunities and challenges across the region. Booming APAC MedTech…
AMA Scheduled to Deliberate Potential Approval of Additional Digital Medicine CPT Codes
As part of its upcoming meeting in mid-September, members of the American Medical Association’s (AMA) CPT Editorial Panel will consider several new Current Procedural Terminology (CPT) codes that identify digital diagnostic and therapeutic procedures. Between this…
Reimbursement Landscape for Digital Medicine Continues to Advance with CMS
The Centers for Medicare and Medicaid Services (CMS) recently announced several new payment and coding proposals that, once finalized, would recognize and advance the use of digital diagnostic and therapeutic modalities. In this week’s update, we…
In the Emerging World of Prescription Digital Therapeutics (PDTs), Can You Really be Prescriptive?
Posted by
Anindita Banerjee on 7 月 13, 20227/13/22
Breaking Down the 5Cs of Clinical and Commercial Success The past 2+ years of my 12-year career as a client strategy and services lead has thrown me into the ever-evolving world of prescription digital therapeutics (PDTs).…
Exploring a Need for Change of Clinical Trials in Digital Medicine | A DTx Europe Panel Discussion
Martin Culjat, Senior VP, Regulatory Innovation & Digital Medicine, EVERSANA joined a panel of experts at DTx Europe to discuss the need for change of clinical trials in digital medicine. The current framework for clinical trials in…
Booming but Constrained: Digital Therapeutics for Mental Health in APAC
Digital therapeutics (DTx) are a fast-emerging class of therapies that use software to treat disease, both as standalone treatments and for treatment optimization. Applications range from improving patient adherence to supporting physicians in managing patients remotely.…
FDA Moves Cybersecurity Into the Product Life Cycle
Due to rising cyber-attacks and the potential to cause harm to patients, medical facilities and hospitals, the U.S. Food and Drug Administration (FDA) has recently increased scrutiny of cyber controls in FDA premarket submissions of medical…
New Legislation Supports Payment for Digital Therapeutics
Earlier this month, the Access to Digital Prescription Therapeutics Act of 2022 was introduced by Rep. Mike Thompson (D-CA) to the U.S. House of Representatives as H.R. 7051 and by Sen. Shelley Moore Capito (R-WV) to…
Gene Therapy in Today’s Digital World
Rare diseases are an emerging global public health priority, with a staggering impact on the more than 300 million people worldwide who are living with them. There are more than 6,000 rare diseases, 72% of which…
How Can Utilizing Digital Therapeutics Provide Better Care to the Veteran Population?
EVERSANA’s Joe Perekupka, Chief Commercial Officer, participated in a keynote panel discussion at the recent DTx West Summit: “How Can Utilizing Digital Therapeutics Provide Better Care to the Veteran Population?” Joe was joined by moderator Debra…